Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

5-Methyl-DL-tryptophan

5-Methyl-DL-tryptophan

951-55-3

DISCOVER
Tamoxifen Citrate

Tamoxifen Citrate

54965-24-1

DISCOVER
Mannose Triflate

Mannose Triflate

92051-23-5

DISCOVER
Topiramate

Topiramate

97240-79-4

DISCOVER
Tylvalosin tartrate

Tylvalosin tartrate

63428-13-7

DISCOVER
Tetracaine Hydrochloride

Tetracaine Hydrochloride

136-47-0

DISCOVER
3E,8Z-Tetradecadienyl Acetate

3E,8Z-Tetradecadienyl Acetate

163041-87-0

DISCOVER
UBIDECARENONE CRS (70 MG)

UBIDECARENONE CRS (70 MG)

303-98-0

DISCOVER
UBIDECARENONE FOR SYSTEM SUITABILITY CRS (1 MG)

UBIDECARENONE FOR SYSTEM SUITABILITY CRS (1 MG)

303-98-0

DISCOVER
UBIDECARENONE IMPURITY D CRS (5 MG)

UBIDECARENONE IMPURITY D CRS (5 MG)

303-97-9

DISCOVER
URACIL ARABINOSIDE CRS (60 MG)

URACIL ARABINOSIDE CRS (60 MG)

NA

DISCOVER
Ursodeoxycholic Acid 13C24

Ursodeoxycholic Acid 13C24

63296-46-8

DISCOVER